Skip to main
Ulysseus Science
Communities
My dashboard
New upload
New community
Log in

S

L

SARMATI , L

Last name: SARMATI

First name: L

    Recent uploads

  • 2024 (v1)
    Publication
    Metadata-only
    Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort
    d'Arminio Monforte, Antonella Tavelli, Alessandro Di Biagio, Antonio

    Objectives: To assess the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) among people poorly represented in clinical trials and potentially at higher risk of suboptimal response to ART. Methods: Observational cohort study on persons with HIV (PWH) enrolled in ICONA who started BIC/FTC/TAF as initial therapy or as...

    Uploaded on: July 3, 2024
  • 2024 (v1)
    Publication
    Metadata-only
    Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort
    d'Arminio Monforte, Antonella Tavelli, Alessandro Di Biagio, Antonio

    Objectives: To assess the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) among people poorly represented in clinical trials and potentially at higher risk of suboptimal response to ART. Methods: Observational cohort study on persons with HIV (PWH) enrolled in ICONA who started BIC/FTC/TAF as initial therapy or as...

    Uploaded on: July 3, 2024
  • 2024 (v1)
    Publication
    Metadata-only
    Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort
    d'Arminio Monforte, Antonella Tavelli, Alessandro Di Biagio, Antonio

    Objectives: To assess the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) among people poorly represented in clinical trials and potentially at higher risk of suboptimal response to ART. Methods: Observational cohort study on persons with HIV (PWH) enrolled in ICONA who started BIC/FTC/TAF as initial therapy or as...

    Uploaded on: July 3, 2024

About Ulysseus

Main website

Join our research network

Match4Cooperation

Powered by InvenioRDM